» Download Public Reports
About 400 reports
- Industry report
- May 2013
- 26 pages
... China & india india (reassessment of previous aggressive strategies) independent expert committees: feb 2013 to formulate guidelines: Approval of new drugs clinical trials Banning of drugs ...
May 2013
... The press key challenges in pharmaceutical industry increase in cost of drug discovery & development increasing time to market impending patent expirations of blockbuster molecules pricing pressure ...
April 2013
... Progression modelling at gsk, uk and chdr, the netherlands danny lowe, cfo part time: previously cfo for several public companies in the drug discovery, alternative energy and mineral resources sector advisors ...
April 2013
... Refund : after completion of phase ii trial, if jiangsu neptunus decides not to proceed with the next clinical trial by reason of safety and effectiveness of the recombinant technology, shenzhen neptunus ...
April 2013
... And insurance for clinical research besides trials a lot of clinical research not covered by the pharmaceutical affairs act is conducted in many education-related hospitals such as university hospitals ...
April 2013
... D productivity by shortening drug-development times and delivering the highest-quality services. We work with our customers to provide them with the capabilities and capacity they need throughout the drug ...
March 2013
... Costs were to increase as multiple clinical trials are conducted simultaneously). 3Dm was planning on starting clinical trials for several pipeline applications, such as its alveolar bone reconstruction ...
February 2013
... The challenges of proving its efficiency as the preferred destination for global clinical trials. A number of factors favour india as a clinical research hub. Firstly, there are numerous government funded medical ...
» Purchase Premium Reports
(From $ 125 - $ 2 000)
About 200 reports
- $ 2 000
- Company report
- May 2013
- by Global Markets Direct
Intermittent Claudication - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Intermittent Claudication - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. ...
April 2013
$ 1 500
The report includes data on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from ...
June 2013
$ 1 495
Executive Summary China possesses a fourth population in the world and has one of the largest drug markets round the world. By 2012, sales on the Chinese drug market have reached RMB 926.1billion (about ...
April 2013
$ 750
Since the reform and open door policy implemented by Chinese authorities in the late 1970s, the door of the Chinese drug market began opening up to the world step by step, which gave a fillip to the imported ...
May 2013
$ 750
Summary JetGuide Ltd. (JetGuide) is a medical device company. The company develops systems for real-time intraoperative monitoring with feedback throughout processes of surgical procedures of bone drilling ...
May 2013
$ 750
China Pharmaceutical Guidebook Series (3) 2013 Edition Material and Clinical Trial Requirements of Application and Approval for Imported Drug Registration: A Guidebook of Registration Application for Imported ...
May 2013
$ 750
Summary Perfint Healthcare Pvt. Ltd. (Perfint) is a medical device company. The company develops medical devices for the healthcare market. Its products include Maxio, Robio EX, Robio EZ and Robio. Robio ...